The rapid advancement of cell and gene therapies offers unprecedented potential to treat complex diseases, but navigating both scientific and financial challenges remains a significant hurdle. From developing robust clinical trials to securing funding for research, biotech companies face a dual challenge in bringing these transformative treatments to market. This article explores the key obstacles and innovative solutions that are driving the next wave of breakthroughs in cell and gene therapy.
